Dr. Leah Schiffman

Recommended Articles

• Soccer Player with Cystic Fibrosis Overcomes Adversity

  Sports and high school. The two go together like ice cream and apple pie. Playing sports in high school not only provides much needed physical exercise for adolescents, but also offers a social outlet and a way to make friends and bring families together for games.For children with chronic diseases,...

• Can Pleurisy Destroy My Lungs?

  What is pleurisy?Pleurisy is the inflammation of the thin pleural membranes that line the lungs.What happens in pleurisy?A thin membrane called the pleura lines your lungs. The pleura are double-layered membranes that line your lungs as well as the inner aspect of the chest wall. Between these...

• Marvel Comics Supports Cody Sheehan's Captain America Campaign for Cystic Fibrosis

  Cystic fibrosis is a genetic condition that afflicts individuals from birth. Over the years, the prognosis of the condition has gotten far better, but at one point in time, the disease was so devastating that individuals diagnosed at birth rarely lived past childhood. Such was the case for Cody...

• Asthmatic Bronchitis: Symptoms, Causes, and Treatments

  IntroductionEvery time you inhale, air enters your nose and mouth, and then flows down the throat through the air passageways called as bronchial tubes. For the air to reach the lungs, these passageways need to be open. To transport the oxygen to the tissues of the body, oxygen is passed into the...

• It’s Important: What People With CF Want Their Doctors to Know

  Doctors and nurses are a group of professionals that are vital to patients’ health. Often times, such as when dealing with a chronic condition like cystic fibrosis (CF), some of these professionals can become like family due to how frequently you see them. And in a majority of cases, through...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...